This data supports further study into the potential clinical relevance of at least a couple of these breast CSC-associated lncRNAs (i.e., NRAD/LINC00284 and DANCR) alongside potential protein targets, in the treatment of TNBC and basal-like breast cancers. Here, DANCR is linked to breast carcinoma.